CL
Colgate-Palmolive Company
Colgate-Palmolive Company insider trading
Colgate-Palmolive Company files with the SEC as a Perfumes, Cosmetics & Other Toilet Preparations company headquartered in New York, NY. Every time one of its executives or directors buys or sells the stock, the filing appears here the moment it reaches the SEC — with grants and option exercises set apart from the trades that cost the insider their own money.
From SEC filings
Recent CL insider transactions
4 insiders traded CL on the open market between May 15, 2026 and Aug 24, 2026 — 5 sales worth $31.2M.
- Bought
- —
- Sold
- $31.2M
- Net
- −$31.2M
- Insiders
- 4
none on a 10b5-1 plan
Tsourapas Panagiotis
COO, CD, EMEA, APac, Skin
−$920.5K
Aug 24, 2026
10,000 sh · $92.05
Cahill John T
Director
−$389.4K
Aug 06, 2026
4,170 sh · $93.37
Wallace Noel R.
Chairman, President & CEO · Director
−$14.9M
Aug 05, 2026
161,021 sh · $92.52
Wallace Noel R.
Chairman, President & CEO · Director
−$14.8M
Aug 04, 2026
161,021 sh · $91.92
Malcolm Gregory
EVP and Controller
−$203.4K
May 15, 2026
2,300 sh · $88.44
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Aug 24, 2026 | Tsourapas PanagiotisCOO, CD, EMEA, APac, Skin | 10,000 | $92.05 | −$920.5K |
| Aug 06, 2026 | Cahill John TDirector | 4,170 | $93.37 | −$389.4K |
| Aug 05, 2026 | Wallace Noel R.Chairman, President & CEO · Director | 161,021 | $92.52 | −$14.9M |
| Aug 04, 2026 | Wallace Noel R.Chairman, President & CEO · Director | 161,021 | $91.92 | −$14.8M |
| May 15, 2026 | Malcolm GregoryEVP and Controller | 2,300 | $88.44 | −$203.4K |
SEC Form 4 data, Q3 2024 to Q2 2026
CL insider trading by quarter
Between Jul 01, 2024 and Jun 30, 2026, 9 insiders traded CL on the open market: 0 purchases and 25 sales worth $54.4M, 1 of the sales pre-scheduled under a 10b5-1 plan. In the last four quarters alone: 0 purchases and 11 sales ($26.1M), by 7 insiders.
| Quarter | Bought | Sold | Insiders |
|---|---|---|---|
| Q2 2026 | — | −$955.1K2 sales | |
| Q1 2026 | — | −$25.1M8 sales | |
| Q4 2025 | — | −$100.1K1 sale | |
| Q3 2025 | — | — | |
| Q2 2025 | — | −$200.2K1 sale | |
| Q1 2025 | — | −$736.2K1 sale | |
| Q4 2024 | — | −$14.1M5 sales · 1 on a plan | |
| Q3 2024 | — | −$13.3M7 sales |
- Largest sale
- −$9.2M of CL by Sutula Stanley J III (Chief Financial Officer) on Feb 04, 2026.
Open-market transactions through Jun 30, 2026most recent first
Massey Sally
Chief People Officer
−$751.6K
May 07, 2026
8,599 sh · $87.41
Tsourapas Panagiotis
COO, Eur., APac, Afr Eur, Skin
−$1.5M
Feb 12, 2026
15,000 sh · $97.81
Tsourapas Panagiotis
COO, Eur., APac, Afr Eur, Skin
−$3.3M
Feb 11, 2026
35,000 sh · $94.61
Hazlin John
Chief Growth Officer
−$2M
Feb 10, 2026
20,989 sh · $94.25
Malcolm Gregory
EVP and Controller
−$1.2M
Feb 06, 2026
12,747 sh · $94.91
Massey Sally
Chief Human Resources Officer
−$1.5M
Feb 05, 2026
15,851 sh · $95.03
Sutula Stanley J III
Chief Financial Officer
−$9.2M
Feb 04, 2026
97,843 sh · $94.27
Wallace Noel R.
Chairman, President & CEO · Director
−$4.3M
Feb 04, 2026
45,568 sh · $93.91
Daniels Jennifer
CLO and Secretary
−$2.1M
Feb 04, 2026
22,000 sh · $94.34
Massey Sally
Chief Human Resources Officer
−$100.1K
Nov 21, 2025
1,237 sh · $80.89
Massey Sally
Chief Human Resources Officer
−$200.2K
May 15, 2025
2,250 sh · $88.97
Massey Sally
Chief Human Resources Officer
−$736.2K
Feb 25, 2025
8,000 sh · $92.02
Malcolm Gregory
EVP and Controller
−$101.1K
Nov 26, 2024
1,054 sh · $95.94
Wallace Noel R.10b5-1
Chairman, President & CEO · Director
−$3.2M
Nov 22, 2024
33,333 sh · $95.00
Sutula Stanley J III
Chief Financial Officer
−$4.3M
Nov 05, 2024
45,410 sh · $94.11
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| May 07, 2026 | Massey SallyChief People Officer | 8,599 | $87.41 | −$751.6K |
| Feb 12, 2026 | Tsourapas PanagiotisCOO, Eur., APac, Afr Eur, Skin | 15,000 | $97.81 | −$1.5M |
| Feb 11, 2026 | Tsourapas PanagiotisCOO, Eur., APac, Afr Eur, Skin | 35,000 | $94.61 | −$3.3M |
| Feb 10, 2026 | Hazlin JohnChief Growth Officer | 20,989 | $94.25 | −$2M |
| Feb 06, 2026 | Malcolm GregoryEVP and Controller | 12,747 | $94.91 | −$1.2M |
| Feb 05, 2026 | Massey SallyChief Human Resources Officer | 15,851 | $95.03 | −$1.5M |
| Feb 04, 2026 | Sutula Stanley J IIIChief Financial Officer | 97,843 | $94.27 | −$9.2M |
| Feb 04, 2026 | Wallace Noel R.Chairman, President & CEO · Director | 45,568 | $93.91 | −$4.3M |
| Feb 04, 2026 | Daniels JenniferCLO and Secretary | 22,000 | $94.34 | −$2.1M |
| Nov 21, 2025 | Massey SallyChief Human Resources Officer | 1,237 | $80.89 | −$100.1K |
| May 15, 2025 | Massey SallyChief Human Resources Officer | 2,250 | $88.97 | −$200.2K |
| Feb 25, 2025 | Massey SallyChief Human Resources Officer | 8,000 | $92.02 | −$736.2K |
| Nov 26, 2024 | Malcolm GregoryEVP and Controller | 1,054 | $95.94 | −$101.1K |
| Nov 22, 2024 | Wallace Noel R.10b5-1Chairman, President & CEO · Director | 33,333 | $95.00 | −$3.2M |
| Nov 05, 2024 | Sutula Stanley J IIIChief Financial Officer | 45,410 | $94.11 | −$4.3M |
From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.
Colgate-Palmolive Company company record
- SEC industry classification
- Perfumes, Cosmetics & Other Toilet Preparations
- Headquarters
- New York, NY
- Incorporated in
- DE
- Listed on
- NYSE
- SEC Central Index Key
- 0000021665
Sourced from this company's own SEC submissions record. The industry label is SEC's Standard Industrial Classification, which is more specific than the Consumer Staples sector shown above.
After insiders bought CL
What the stock actually did in the 90 days following each open-market purchase
Don't check CL — let it ping you
Get told the moment an insider moves on CL
Pro watches Colgate-Palmolive Company for you and sends a Telegram ping within moments of a Form 4 clearing EDGAR — a C-suite open-market buy, a cluster, a 10b5-1 regime break — long before it reaches the press. Add CL to a watchlist, see each mover's benchmark-measured track record and which legendary funds hold it, and read the full filing history instead of the last 72 hours.
The live dashboard is free to open. Alerts, watchlists, full filing history and each mover's benchmark-measured track record are Pro. Monitoring, not advice.
How to read CL insider activity
- Open-market purchase (code P)
- An insider spending their own money at market price. This is the only buy code that reliably carries signal — it is a decision, not compensation.
- Grants and option exercises (codes A, M)
- Scheduled compensation. Most "insider buying" headlines are really this, which is why InsiderPulse weights it at a fraction of a real purchase.
- Cluster buy
- Two or more different insiders buying on the open market in the same window. One executive buying can mean anything; three is much harder to explain away.
Other Consumer Staples tickers
Questions
- Are CL insiders buying or selling?
- Between May 15, 2026 and Aug 24, 2026, 4 Colgate-Palmolive Company insiders made no open-market purchases and 5 sales worth $31.2M, a net sale of $31.2M.
- How much CL stock have insiders bought and sold in the last two years?
- Between Jul 01, 2024 and Jun 30, 2026, 9 Colgate-Palmolive Company insiders made no open-market purchases and 25 sales worth $54.4M. 1 of the sales were pre-scheduled under a Rule 10b5-1 plan. In the four quarters to Jun 30, 2026: no purchases and 11 sales ($26.1M). The largest sale was Sutula Stanley J III selling $9.2M on Feb 04, 2026.
- What was the largest recent CL insider trade?
- Wallace Noel R. (Chairman, President & CEO · Director) sold $14.9M of CL stock on Aug 05, 2026 at about $92.52 a share.
- When did an insider last buy CL shares?
- No open-market purchase by a Colgate-Palmolive Company insider appears in the filings from May 15, 2026 to Aug 24, 2026 — every recorded open-market transaction in that period was a sale.
- Where does CL insider trading data come from?
- From the Form 4 filings Colgate-Palmolive Company's officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.
Get the free Insider Brief
Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.